ENDOSCOPIC AND CLINICAL EFFICACY DEMONSTRATED WITH ORAL OZANIMOD IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Brian G. Feagan  1     William Sandborn  2     Geert R. D'Haens  3     Barrett G. Levesque  1     Brett E. Skolnick  4     Caiyan Li  5     Darryl Penenberg     Richard Aranda     Allan Olson    
1 Robarts Research Institute,London,Canada
2 University of California,Division of Gastroenterology,La Jolla, San Diego,United States of America
3 Academic Medical Center,Amsterdam,Netherlands
4 Receptos, a wholly owned subsidiary of Celgene,San Diego,United States of America
5 Receptos, a wholly-own

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing